ArticleNanomaterials (Basel, Switzerland)2019
In Situ Synthesis of a Stable Fe₃O₄@Cellulose Nanocomposite for Efficient Catalytic Degradation of Methylene Blue.
Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Magnetic Cellulose Nanocrystal Composites: Synthesis, Properties, Applications, and Opportunities.Nanomaterials (Basel, Switzerland) · 2026Review
- Self-Assembly Interactions in Magnetite-Coated Cellulose Nanocrystals: Implications for Magnetic Hyperthermia Applications.ACS applied nano materials · 2026Article
- Fast and Facile Synthesis of Cobalt-Doped ZIF-8 and FeACS omega · 2024Article
- Synthesis and Characterization of Novel Magnetic Nano-Biocomposite Hydrogels Based on Starch-ACS omega · 2023Article
- Synthesis of Magnetic Iron Oxide-Incorporated Cellulose Composite Particles: An Investigation on Antioxidant Properties and Drug Delivery Applications.Pharmaceutics · 2023Article
- Cellulose derived Pd nano-catalyst for efficient catalysis.RSC advances · 2022Article
- Biosynthesis of chitosan-coated iron oxide (Fe3 Biotech · 2021Article
- Telescopic synthesis of cellulose nanofibrils with a stable dispersion of Fe(0) nanoparticles for synergistic removal of 5-fluorouracil.Scientific reports · 2019Article
- Preparation of a Stable Nanoscale Manganese Residue-Derived FeS@Starch-Derived Carbon Composite for the Adsorption of Safranine T.Nanomaterials (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
To rapidly obtain a stable Fe₃O₄@cellulose heterogeneous Fenton catalyst, a novel in situ chemical co-precipitation method was developed. Compared with mechanical activation (MA)-pretreated cellulose (MAC), MA + FeCl₃ (MAFC)-pretreated cellulose (MAFCC) was more easily dissolved and uniformly distributed in NaOH/urea solvent. MAFCC and MAC solutions were used as precipitators to prepare Fe₃O₄@MAFCC and Fe₃O₄@MAC nanocomposites, respectively. MAFCC showed stronger interaction and more uniform combination with Fe₃O₄ nanoparticles than MAC, implying that MAFC pretreatment enhanced the accessibility, reactivity, and dissolving capacity of cellulose thus, provided reactive sites for the in situ growth of Fe₃O₄ nanoparticles on the regenerated cellulose. Additionally, the catalytic performance of Fe₃O₄@MAFCC nanocomposite was evaluated by using for catalytic degradation of methylene blue (MB), and Fe₃O₄@MAC nanocomposite and Fe₃O₄ nanoparticles were used for comparative studies. Fe₃O₄@MAFCC nanocomposite exhibited superior catalytic activity for the degradation and mineralization of MB in practical applications. After ten cycles, the structure of Fe₃O₄@MAFCC nanocomposite was not significantly changed owing to the strong interaction between MAFCC and Fe₃O₄ nanoparticles. This study provides a green pathway to the fabrication of a stable nanocomposite catalyst with high catalytic performance and reusability for the degradation of organic pollutants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.